TWI370135B - Analogs of ghrelin substituted at the n-terminal - Google Patents

Analogs of ghrelin substituted at the n-terminal

Info

Publication number: TWI370135B
Authority: TW; Taiwan
Prior art keywords: ghrelin; analogs; substituted; terminal; ghrelin substituted
Prior art date: 2006-09-27

Application number

TW096135656A

Other languages

English (en)

Other versions

TW200821328A (en

Inventor

Zheng Xin Dong

Original Assignee

Ipsen Pharma Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-27

Filing date

2007-09-26

Publication date

2012-08-11

2007-09-26 Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas

2008-05-16 Publication of TW200821328A publication Critical patent/TW200821328A/zh

2012-08-11 Application granted granted Critical

2012-08-11 Publication of TWI370135B publication Critical patent/TWI370135B/zh

Links

102000012004 Ghrelin Human genes 0.000 title 1
101800001586 Ghrelin Proteins 0.000 title 1
GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical group C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physical Education & Sports Medicine (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Obesity (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Toxicology (AREA)
Nutrition Science (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Cardiology (AREA)

TW096135656A 2006-09-27 2007-09-26 Analogs of ghrelin substituted at the n-terminal TWI370135B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US84742306P	2006-09-27	2006-09-27

Publications (2)

Publication Number	Publication Date
TW200821328A TW200821328A (en)	2008-05-16
TWI370135B true TWI370135B (en)	2012-08-11

Family

ID=39230783

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW096135656A TWI370135B (en)	2006-09-27	2007-09-26	Analogs of ghrelin substituted at the n-terminal

Country Status (16)

Country	Link
US (1)	US8299022B2 (zh)
EP (1)	EP2083842B1 (zh)
JP (1)	JP5134627B2 (zh)
KR (1)	KR101197541B1 (zh)
CN (1)	CN101541341B (zh)
AR (1)	AR061780A1 (zh)
AU (1)	AU2007300526B2 (zh)
BR (1)	BRPI0717169C1 (zh)
CA (1)	CA2664558C (zh)
ES (1)	ES2436419T3 (zh)
IL (1)	IL197796A (zh)
MX (1)	MX2009003246A (zh)
NZ (1)	NZ576470A (zh)
RU (1)	RU2459831C2 (zh)
TW (1)	TWI370135B (zh)
WO (1)	WO2008039415A2 (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007038678A2 (en) *	2005-09-28	2007-04-05	Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S.	Analogs of ghrelin
RU2420305C2 (ru)	2005-09-29	2011-06-10	Ипсен Фарма С.А.С.	Композиции и способы стимуляции двигательной функции желудочно-кишечного тракта
EP3159352B1 (en)	2007-03-28	2023-08-02	President and Fellows of Harvard College	Stitched polypeptides
US9724381B2 (en) *	2009-05-12	2017-08-08	The Administrators Of The Tulane Educational Fund	Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
US8628554B2 (en)	2010-06-13	2014-01-14	Virender K. Sharma	Intragastric device for treating obesity
US10420665B2 (en)	2010-06-13	2019-09-24	W. L. Gore & Associates, Inc.	Intragastric device for treating obesity
US10010439B2 (en)	2010-06-13	2018-07-03	Synerz Medical, Inc.	Intragastric device for treating obesity
US9526648B2 (en)	2010-06-13	2016-12-27	Synerz Medical, Inc.	Intragastric device for treating obesity
SI2603600T1 (sl)	2010-08-13	2019-04-30	Aileron Therapeutics, Inc.	Peptidomimetični makrocikli
EP2768518A4 (en)	2011-10-18	2015-05-27	Aileron Therapeutics Inc	PEPTIDOMIMETIC MACROCYCLES
WO2013113916A2 (en) *	2012-02-03	2013-08-08	Zealand Pharma A/S	Ghrelin analogues
US10039813B2 (en)	2012-02-07	2018-08-07	Massachusetts Institute Of Technology	Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
US8927500B2 (en)	2012-02-15	2015-01-06	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles
WO2013123267A1 (en)	2012-02-15	2013-08-22	Aileron Therapeutics, Inc.	Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
ES2959427T3 (es)	2012-09-27	2024-02-26	Elanco Animal Health Incorporated	Composiciones farmacéuticas para el tratamiento de la inapetencia
AU2013337388B2 (en)	2012-11-01	2018-08-02	Aileron Therapeutics, Inc.	Disubstituted amino acids and methods of preparation and use thereof
WO2014144231A1 (en)	2013-03-15	2014-09-18	Massachusetts Institute Of Technology	Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
JP6295247B2 (ja) *	2013-03-25	2018-03-14	ゼリア新薬工業株式会社	食後期の胃運動亢進剤
CN106459149A (zh) *	2014-03-04	2017-02-22	莫图斯治疗公司	H‑inp‑(d)bal‑(d)trp‑phe‑apc‑nh2及其可药用盐的液相合成的方法
MX2017003797A (es)	2014-09-24	2017-06-15	Aileron Therapeutics Inc	Macrociclos peptidomimeticos y usos de los mismos.
KR20180108916A (ko)	2015-01-28	2018-10-04	아라타나 세라퓨틱스, 인크.	체중-증량 화합물의 장기 사용을 위한 조성물 및 방법
US10317418B2 (en)	2015-02-24	2019-06-11	Massachusetts Institute Of Technology	Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
CN107614003A (zh)	2015-03-20	2018-01-19	艾瑞朗医疗公司	拟肽大环化合物及其用途
US10779980B2 (en)	2016-04-27	2020-09-22	Synerz Medical, Inc.	Intragastric device for treating obesity
KR102690573B1 (ko) *	2020-06-26	2024-07-31	숙명여자대학교산학협력단	사이클로덱스트린을 이용한 경구투여용 복합 조성물 및 이의 제조방법
WO2023161226A1 (en) *	2022-02-22	2023-08-31	Pephexia Therapeutics Aps	Ghrelin agonists with improved potency
WO2024003381A1 (en) *	2022-07-01	2024-01-04	Pephexia Therapeutics Aps	Hybrid polypeptides acting as dual ghsr and npy5r agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6124263A (en)	1998-11-16	2000-09-26	Asta Medica Ag	Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
ES2288151T3 (es)	1999-07-23	2008-01-01	Kenji Kangawa	Nuevos peptidos.
US6967237B2 (en) *	2000-05-30	2005-11-22	Merck & Co., Inc.	Ghrelin analogs
CN100411683C (zh) *	2002-05-21	2008-08-20	阿斯比奥制药株式会社	含有生长素释放肽的药物组合物
JP2006515271A (ja)	2002-07-23	2006-05-25	ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス	グレリン類似体
TWI331922B (en) *	2002-08-09	2010-10-21	Ipsen Pharma Sas	Growth hormone releasing peptides
DE602004012207T2 (de) *	2003-10-16	2009-03-12	F. Hoffmann-La Roche Ag	Fluoreszent markierte Ghrelin-Peptide
WO2007038678A2 (en)	2005-09-28	2007-04-05	Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S.	Analogs of ghrelin
US20100227806A1 (en) *	2006-03-10	2010-09-09	Tulipano Giovanni	Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment

2007
- 2007-09-24 US US12/311,409 patent/US8299022B2/en not_active Expired - Fee Related
- 2007-09-24 RU RU2009115711/04A patent/RU2459831C2/ru not_active IP Right Cessation
- 2007-09-24 NZ NZ576470A patent/NZ576470A/xx not_active IP Right Cessation
- 2007-09-24 CA CA2664558A patent/CA2664558C/en not_active Expired - Fee Related
- 2007-09-24 BR BRC10717169-2A patent/BRPI0717169C1/pt not_active IP Right Cessation
- 2007-09-24 KR KR1020097008570A patent/KR101197541B1/ko not_active Expired - Fee Related
- 2007-09-24 MX MX2009003246A patent/MX2009003246A/es active IP Right Grant
- 2007-09-24 CN CN2007800436254A patent/CN101541341B/zh not_active Expired - Fee Related
- 2007-09-24 AU AU2007300526A patent/AU2007300526B2/en not_active Ceased
- 2007-09-24 WO PCT/US2007/020595 patent/WO2008039415A2/en not_active Ceased
- 2007-09-24 EP EP07838741.2A patent/EP2083842B1/en active Active
- 2007-09-24 ES ES07838741.2T patent/ES2436419T3/es active Active
- 2007-09-24 JP JP2009530382A patent/JP5134627B2/ja not_active Expired - Fee Related
- 2007-09-26 TW TW096135656A patent/TWI370135B/zh not_active IP Right Cessation
- 2007-09-26 AR ARP070104255A patent/AR061780A1/es not_active Application Discontinuation
2009
- 2009-03-25 IL IL197796A patent/IL197796A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
MX2009003246A (es)	2009-07-29
TW200821328A (en)	2008-05-16
EP2083842B1 (en)	2013-08-28
CA2664558C (en)	2016-11-01
IL197796A0 (en)	2011-08-01
JP2010504966A (ja)	2010-02-18
WO2008039415A3 (en)	2008-11-13
US20090275511A1 (en)	2009-11-05
WO2008039415A2 (en)	2008-04-03
RU2009115711A (ru)	2010-11-10
RU2459831C2 (ru)	2012-08-27
BRPI0717169C1 (pt)	2012-12-04
IL197796A (en)	2015-09-24
BRPI0717169A2 (pt)	2012-10-23
EP2083842A4 (en)	2011-03-16
KR101197541B1 (ko)	2013-01-02
JP5134627B2 (ja)	2013-01-30
AU2007300526A1 (en)	2008-04-03
CN101541341B (zh)	2013-06-05
AU2007300526B2 (en)	2011-07-21
KR20090075838A (ko)	2009-07-09
AR061780A1 (es)	2008-09-24
US8299022B2 (en)	2012-10-30
CA2664558A1 (en)	2008-04-03
CN101541341A (zh)	2009-09-23
EP2083842A2 (en)	2009-08-05
ES2436419T3 (es)	2014-01-02
NZ576470A (en)	2012-09-28

Publication	Publication Date	Title
TWI370135B (en)	2012-08-11	Analogs of ghrelin substituted at the n-terminal
HUS1900033I1 (hu)	2019-07-29	Szubsztituált enaminokarbonil vegyületek
IL194120A0 (en)	2011-08-01	Stabilized polypeptide compositions
ZA200810738B (en)	2018-11-28	Polypeptide
ZA200904445B (en)	2010-12-29	Cyclopamine analogs
AU315107S (en)	2007-07-10	Wristwatch
ZA201006127B (en)	2011-10-26	4'4'-dioxaspiro-spirocyclically substituted tetramates
GB0706536D0 (en)	2007-05-09	Vibrator
GB0703267D0 (en)	2007-03-28	Vibrator
GB0700345D0 (en)	2007-02-14	Vibrator
ZA201000283B (en)	2011-06-29	Reinigung pegylierter polypeptide
IL192799A0 (en)	2009-02-11	Substituted 4-phenylpiperidines
IL189996A0 (en)	2008-08-07	Stabilized glp-1 analogs
EP1928489A4 (en)	2009-11-11	Ghrelin Analogs
ZA200807964B (en)	2009-10-28	Stabilized polypeptide compositions
ZA200902467B (en)	2010-03-31	Stabilized prostaglandin E composition
IL198412A0 (en)	2010-02-17	Pyrazole analogs
ZA200903382B (en)	2010-04-28	Substituted 4-imidazoles
IL193427A0 (en)	2011-08-01	Polypeptide antagonist
GB201000798D0 (en)	2010-03-03	Poly-TLR antagonists
HUP0800625A2 (en)	2009-05-28	Reducing the helting point of modified moru-hightemperature solder
ZA200901570B (en)	2010-05-26	Substituted azolin-2-YL-amino compounds
DE502007005664D1 (en)	2010-12-30	Bob
EP2204379A4 (en)	2010-12-22	POLYPEPTIDE COMPOUND
PL381142A1 (pl)	2008-05-26	Sposób otrzymywania glicydolu

Legal Events

Date	Code	Title	Description
2018-05-11	MM4A	Annulment or lapse of patent due to non-payment of fees